A Study To Compare Pharmacokinetics Of Dacomitinib (PF-00299804) Between Healthy Subjects And Subjects With Mild And Moderate Hepatic Impairment

NCT01571388 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Otherwise Healthy Volunteers With Mild or Moderate Hepatic Dysfunction

Interventions

DRUG: dacomitinib
DRUG: dacomitinib
DRUG: dacomitinib

Sponsor

Pfizer